WebFeb 27, 2024 · Anti-glomerular basement membrane disease (GBM) disease is a rare autoimmune disease causing rapidly progressive glomerulonephritis and pulmonary haemorrhage. Recently, an association between COVID-19 and anti-glomerular basement membrane (anti-GBM) disease has been proposed. We report on a patient with … WebJan 7, 2024 · Background Glioblastoma (GBM) infrequently recurs in the infratentorial region. Such Infratentorial recurrence (ITR) has some clinically unique characteristics, such as presenting unspecific symptoms and providing patients a chance to receive additional radiotherapy. However, the clinical significances of ITR are not well studied. Methods We …
Study shows TTFields holds promise to ... - University of Florida
WebGlioblastoma (GBM) is the most common primary malignant brain tumor among adults [].Despite treatment with surgical resection, radiation therapy (RT), chemotherapy, and … WebDec 19, 2024 · The lipid/lactate peak is markedly elevated in patients with pseudoprogression but is also commonly present in GBM recurrence. DWI. DWI depicts changes in water movement through different tissues, according to the cell count, cell density over the extracellular matrix, and the nucleus-cytoplasm ratio. If these factors … durable power of attorney printable form
Detection of Glioblastoma Subclinical Recurrence Using Serial …
WebOct 1, 2016 · Upon recurrence of GBM, chemotherapy and corticosteroids may be used to palliate symptoms and improve quality of life, but objective response rates are dismal, and time to progression for standard cytotoxic agents is only three to … WebJul 19, 2010 · Purpose Despite initial treatment with surgical resection, radiotherapy, and chemotherapy, glioblastoma multiforme (GBM) virtually always recurs. Surgery is sometimes recommended to treat recurrence. In this study, we sought to devise a preoperative scale that predicts survival after surgery for recurrent glioblastoma … WebApr 13, 2024 · Glioblastoma multiforme (GBM) is a highly malignant intracranial tumor with a median survival of only about 15-17 months after standard treatment. Patients with GBM often experience disease recurrence, and once recurrence occurs, treatment options are very limited, with a median overall survival of only about 6 months. crypto accountant calgary